Ventures
Each project below represents one of the four pillars powering my innovation ecosystem. Click the logo of any project to visit its website.
Tiep Research Institute
Grounded in Basics, Guided by Application
Tiep Research Institute (TRI) advances knowledge in neuroscience, psychology, and bioengineering. We conduct a wide spectrum of research—from foundational scientific inquiry to applied investigations—driven by interdisciplinary collaboration and innovative methodologies. Our work deepens understanding, informs practice, and supports the development of technologies and frameworks that elevate human potential.
As a 501(c)(3) nonprofit, TRI serves the public interest through open scientific advancement. Our research aligns with educational and scientific missions by:
- Advancing STEM innovation through biomedical device development, behavioral intervention design, and neuroscientific exploration.
- Supporting public health by investigating addiction, habit formation, and neurobehavioral mechanisms.
- Promoting interdisciplinary education via university partnerships, academic mentorship, and training programs.
- Fostering knowledge transfer and translational research to ensure discoveries lead to real-world impact.
We actively engage with universities, companies, and research institutions whose goals align with ours. Our structured collaborations preserve intellectual property integrity while prioritizing transparency and public access to non-proprietary findings.
As Director, I oversee TRI’s research strategy, institutional development, and ethical framework. We publish in peer-reviewed journals, contribute to open-access repositories, and cultivate partnerships that amplify public understanding.
Recalivape
Empowering Recovery Through Personalization
At Recalivape, I develop adaptive vaporization systems to address nicotine dependence through precision dosing and behavioral insight. Our flagship device, AMSTAD, uses a multi-chamber system integrated with real-time sensors and IoT connectivity to tailor nicotine reduction based on individual usage patterns and physiological feedback.
The inspiration stems from personal experiences with loved ones struggling to quit and from collaborative work with addiction experts who highlighted the limitations of static, one-size-fits-all cessation methods. AMSTAD captures biometric data, vaping frequency, and inhalation behavior to generate a dynamic tapering protocol—helping users reduce dependency without compromising the sensory experience of vaping.
Unlike traditional approaches, AMSTAD autonomously adjusts dosage and integrates haptic feedback, flavor retention, and app-based data visualization. It supports both nicotine salts and freebase nicotine, making it effective for a diverse range of users.
Recalivape is more than a cessation tool—it is a platform for reengineering addiction treatment using adaptive technology. Our work has been recognized by the James Dyson Award, acceptance into MIT’s SUD Ventures Program, and Babson College’s SUD Sprint cohort.
FollowInq
Restoring Trust in Information
I founded FollowInq to restore public trust in media by reengineering how AI handles news and information. At its core, FollowInq is an open-source AI platform that curates objective content by integrating politically balanced community ratings and cross-source verification.
By rating content through diverse ideological lenses and validating facts across multiple independent agencies, our system mitigates hidden algorithmic bias and empowers users with transparent, verifiable news. Unlike traditional models, FollowInq doesn’t just correct existing AI—it redefines how objectivity is built into machine learning from the ground up.
We serve individuals, journalists, and institutions seeking reliable information free from editorial distortion or political manipulation. As CEO, I lead the design of our bias-resistant AI framework, secure strategic partnerships, and shape a scalable roadmap to integrate FollowInq into newsrooms, academia, and policymaking.
FollowInq isn’t just an AI company—it’s a movement to make truth verifiable and trust in information possible again.
VitaWeft
Weaving the Future of Health
At VitaWeft, I am developing a next-generation bioprinter designed to democratize access to advanced tissue engineering through affordability, modularity, and open-source innovation. Inspired by the mythological Threads of Life, VitaWeft embodies a commitment to precision, complexity, and ethical responsibility in biofabrication.
Our platform, codenamed Loom 1, replaces traditional extruders with a novel pump design that minimizes shear stress and preserves cell viability. A dynamic system allows seamless integration of up to 12 bioinks—empowering researchers to print intricate, multi-material structures with unprecedented flexibility.
Unlike high-cost commercial systems, VitaWeft balances cost-effectiveness with performance, enabling even resource-limited institutions to participate in cutting-edge regenerative medicine, drug discovery, and educational innovation. By embracing open-source collaboration, we foster a growing community of researchers committed to expanding the possibilities of bioprinting.
As Founder, I lead hardware development, strategic planning, and ethical governance. VitaWeft is not just building a printer—it’s weaving a scalable ecosystem to transform how we engineer life.